Reply to Beechar et al. on Donor-Derived Infections
Author Information
Author(s): Carl Boodman, Oscar Fernandez Garcia, Dima Kabbani, Armelle Perez Cortes Villalobos, Johan van Griensven, Karen Doucette
Primary Institution: University of Manitoba
Hypothesis
The necessity of evaluating the consequences of screening high-risk solid organ transplant donors and recipients for Bartonella quintana infection.
Conclusion
The authors emphasize the need for more data and propose a system to screen and monitor individuals at elevated risk of donor-derived B quintana infection.
Supporting Evidence
- B quintana is treatable, and screening should not delay organ transplantation.
- Cases of donor-derived B quintana have been identified in multiple jurisdictions.
- B quintana endocarditis has a fatality rate of approximately 10% despite treatment.
- Guideline recommendations should be based on robust studies, but data on emerging diseases is often lacking.
Takeaway
This study talks about a disease that can be passed from organ donors to transplant patients and suggests ways to check for it so that patients can be treated quickly.
Methodology
The authors propose a combination of different diagnostic tests and epidemiologic risk factors to identify individuals at high risk of B quintana infection.
Potential Biases
The opinion expressed may be limited by circular reasoning regarding the evidence base for an emerging disease.
Limitations
Robust data on B quintana infection is limited, especially for neglected infections linked to poverty.
Participant Demographics
The study discusses cases primarily from Alberta, Canada, involving organ transplant recipients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website